◀ Back to JUN
IL18 — JUN
Pathways - manually collected, often from reviews:
-
OpenBEL Selventa BEL large corpus:
JUN
→
IL18
(increases)
Chandrasekar et al., J Biol Chem 2006*
Evidence: ELISA of nuclear proteins revealed a significant increase in c-Fos, Fra-1, and c-Jun and, to smaller extent, in FosB and JunB. Fra-2 and JunD levels were not modulated by IL-18 (Fig. 7B).
-
OpenBEL Selventa BEL large corpus:
JUN
→
IL18
(increases, IL18 Activity)
Chandrasekar et al., J Biol Chem 2006*
Evidence: The results in Fig. 7D show that antisense ODN targeting of c-Fos, c-Jun, and Fra-1 significantly attenuated MMP9 transcription. In contrast, ectopic expression of c-Fos, c-Jun, and Fra-1 inducedMMP9transcription (Fig. 7E).
Text-mined interactions from Literome
Seppänen et al., Oncol Res 1998
(Adenocarcinoma...) :
In the present study, we have investigated the
effects of interferons-alpha (IFN-alpha) and -gamma ( IFN-gamma ),
interleukin-10 (IL-10) and -13 ( IL-13 ), transforming growth factor-beta1 ( TGF-beta1 ), granulocyte-macrophage colony stimulating factor ( GM-CSF ), and tumor necrosis factor-alpha (TNF-alpha) on cell proliferation and induction of transcription factors
AP-1 and NF-kappaB in UM-EC-3 human endometrial adenocarcinoma cells and UT-OC-5 ovarian carcinoma cells in vitro
Guo et al., Immunopharmacology 2000
:
Antisense IRAK-1 oligonucleotide blocks activation of NF-kappa B and
AP-1 induced by
IL-18 ... Interleukin-1 receptor associated kinase-1 ( IRAK-1 ) has recently been shown to be involved in
IL-18 stimulated activation of NF-kappaB and
AP-1 ... The purpose of this study is to investigate the effects of preventing IRAK-1 expression by antisense IRAK-1 oligodeoxynucleotide ( ODN ) on
IL-18 stimulated activation of NF-kappaB and
AP-1 ... As a result, antisense IRAK-1 ODN attenuated
IL-18 induced
activation of NF-kappaB and
AP-1 as measured by sandwich ELISA in a concentration ( 1-8 microg ml(-1) ) - and time ( 5-24 h ) -dependent fashion
Greene et al., J Immunol 2000
(Sarcoidosis, Pulmonary) :
We examined the
effects of
IL-18 on
AP1 and NF-kappaB in Jurkat T cells in vitro
Nakahira et al., J Immunol 2002
:
Synergy of IL-12 and IL-18 for IFN-gamma gene expression : IL-12 induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of
IL-18 induced
activator protein 1 ... An increase in c-Jun, a component of AP-1, in the nuclear compartment was elicited by stimulation with either IL-12 or IL-18, but accumulation of serine phosphorylated
c-Jun was
induced only by
IL-18 capable of activating c-Jun N-terminal kinase
Liacini et al., Matrix Biol 2002
(Osteoarthritis, Hip) :
Inhibition of
interleukin-1 stimulated MAP kinases,
activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes
Morel et al., J Biol Chem 2002
(Arthritis, Rheumatoid...) :
Electrophoretic mobility shift assay showed that
activator protein-1 (AP-1) is
activated by
IL-18 through ERK and Src but not through PI3-kinase
Cho et al., Biochem Biophys Res Commun 2002
:
The enhanced
IL-18 production by UVB irradiation
requires ROI and
AP-1 signaling in human keratinocyte cell line ( HaCaT ) ... Furthermore, inhibitors of UVB induced
AP-1 activity, such as PD98059,
blocked enhanced
IL-18 production, indicating that AP-1 activation is required for UVB induced IL-18 production
Sugimoto et al., Eur J Immunol 2003
:
IL-18 , but not IL-12,
induced activator protein-1 (AP-1) responsible for high levels of IFN-gamma promoter activation
Chandrasekar et al., J Biol Chem 2005
:
Src kinase inhibitors PP1 and PP2, phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin and LY294002, Akt inhibitor, the c-Jun N-terminal kinase (JNK) inhibitor SP600125, antisense JNK and dominant negative MyD88, interleukin-1 receptor associated kinase ( IRAK)-1, IRAK4, and phosphatidylinositol 3-kinase expression all attenuated
IL-18 mediated
AP-1 binding and reporter activity, CXCL16 promoter-reporter activity, and CXCL16 expression
Wang et al., Nat Immunol 2006
:
Tumor necrosis factor receptor associated factor 6 ( TRAF6 ) is critical for mediating Toll-like receptor ( TLR )
-interleukin 1 receptor (IL-1R) signaling and subsequent
activation of NF-kappaB and
AP-1 , transcriptional activators of innate immunity
Shen et al., Curr Eye Res 2009
:
Under high glucose conditions,
interleukin-1beta significantly
increased expression of
c-Jun and decreased the expression of glutamine synthetase
Venkatesan et al., J Mol Cell Cardiol 2010
:
We show for the first time that EMMPRIN stimulates the activation of NF-kappaB,
AP-1 , CREB, and ATF-2 in cardiomyocytes, and
induces IL-18 expression via Rac1 dependent PI3K/Akt/IKK/NF-kappaB and MKK7/JNK/AP-1 signaling
Zhang et al., Zhonghua Jie He He Hu Xi Za Zhi 2010
(Ventilator-Induced Lung Injury) :
[ Expression of intercellular cell adhesion molecule-1,
interleukin-10 and the
activation of
activator protein-1 in ventilator induced lung injury in rabbits ]
Valente et al., J Mol Cell Cardiol 2012
(Cardiomegaly...) :
Here we report that Ang-II induced CIKS mRNA and protein expression, CIKS binding to IKK and JNK perhaps functioning as a scaffold protein, CIKS dependent IKK/NF-?B and JNK/AP-1 activation, p65 and c-Jun phosphorylation and nuclear translocation, NF-?B- and
AP-1 dependent
IL-18 and MMP-9 induction, and hypertrophy of adult cardiomyocytes isolated from WT, but not CIKS-null mice
Valente et al., Am J Physiol Heart Circ Physiol 2012
(Hyperplasia) :
ANG II-induced superoxide generation, NF-?B and
AP-1 activation, and
IL-18 and MMP-9
induction were all markedly attenuated by losartan, diphenyleneiodonium chloride ( DPI ), and Nox1 knockdown ... Similar to ANG II, addition of IL-18 also induced superoxide generation,
activated NF-?B and
AP-1 , and stimulated SMC migration and proliferation, in part via Nox1, and both ANG II and
IL-18 induced NOX1 transcription in an AP-1 dependent manner
Byun et al., Biochem Biophys Res Commun 2012
(Inflammation) :
In addition, EGCG treated DCs inhibited lipopolysaccharide (LPS) induced production of pro-inflammatory cytokines ( tumor necrosis factor [TNF ] -a,
interleukin [ IL]-1ß, and IL-6 ) and
activation of mitogen activated protein kinases ( MAPKs ), e.g., extracellular signal regulated kinase 1/2 ( ERK1/2 ), p38,
c-Jun N-terminal kinase (JNK) , and nuclear factor ?B ( NF-?B ) p65 translocation through 67LR
Valente et al., Cell Signal 2013
:
IL-18 induced Nox1 dependent ROS generation, TRAF3IP2 expression, and IKK/NF-?B and
JNK/AP-1 activation
Valente et al., Cell Signal 2013
:
Silencing TRAF3IP2 using a phosphorothioated, 2'-O-methyl modified, cholesterol tagged TRAF3IP2 siRNA duplex markedly attenuated
IL-18 induced NF-?B and
AP-1 activation and CF migration
Sung et al., J Biol Chem 1993
:
Stimulation of
interleukin-1 gene transcription may be
caused by the stimulation of transcription factor activities, including those of
AP-1 , by these protein phosphatase inhibitors
Schwenger et al., Proc Natl Acad Sci U S A 1997
:
c-Jun N-terminal kinase activation
induced by
interleukin 1 or epidermal growth factor was less strongly inhibited by NaSal
Sansbury et al., Carcinogenesis 1997
(Thymoma) :
Phorbol ester induced morphological changes, ERK activation, calcium dependent
activation of the
c-Jun N-terminal kinase (JNK) ,
interleukin-2 synthesis, and growth inhibition in sensitive but not resistant cells
Adachi et al., Immunity 1998
:
Furthermore,
IL-18 induced activation of NF-kappaB and
c-Jun N-terminal kinase (JNK) is blocked in MyD88-/- Th1 developing cells